Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05987553

The Influence of an E-learning Program on Recognition of Actinic Keratosis

The evaluation on the diagnostic accuracy of actinic keratosis recognition by general practitioners before and after participation on an e-learning program.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Actinic Keratoses Dermatology E-learning Keratosis Keratosis, Actinic Neoplasms Precancerous Conditions Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–67 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ellen Oyen

Maastricht, Netherlands

About this study

Actinic keratosis is defined as the most frequent common intra-epithelial neoplasm in the Caucasian population, with an increasing prevalence. If left untreated, actinic keratosis has the potency to develop into a cutaneous squamous-cell carcinoma. Treatment of actinic keratosis is aimed at both lesion reduction and to prevent malignant transformation. To achieve treatment adherence for patients, it is necessary to raise physician awareness about actinic keratosis.

This study primarily aimed to investigate whether the sensitivity of establishing a correct actinic keratosis diagnosis by general practitioners (in training) would increase after participating in an e-learning program about the recognition of actinic keratosis. This was achieved by comparing the results of a pre- and post-test completed by general practitioners which was incorporated in the e-learning program.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • general practitioner in the Netherlands
  • access to e-learning module via phone/computer/tablet
  • knowledge of the Dutch language

Exclusion criteria

  • no knowledge of the Dutch language
  • different specialists than general practitioner

Treatment and study plan

e-learning program

Other

All participants participate in this intervention: an e-learning program about the recognition of actinic keratosis. The program exists of 30 cases. Each case exists of a question and thorough explanation including references to various sources.

Primary outcomes

  1. Difference in sensitivity

    Time frame: Measurement by baseline and after finalising the e-learning program (same day up until 30 days)

    Difference in sensitivity of participants in the recognition of actinic keratosis, before and after the use of an e-learning program (paired).

  2. Difference in specificity

    Time frame: Measurement by baseline and after finalising the e-learning program (same day up until 30 days)

    Difference in specificity of participants in the recognition of actinic keratosis, before and after the use of an e-learning program (paired).

Secondary outcomes

  1. Difference in area under the receiver operating characteristic (ROC) curve

    Time frame: Measurement by baseline and after finalising the e-learning program (same day up until 30 days)

    Difference in area under the curve of participants in the recognition of actinic keratosis, before and after the use of an e-learning program.

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Registry information

Official study title

The Influence of an E-learning Program on Recognition of Actinic Keratosis by General Practitioners). Implementation of Actinic Keratosis Guidelines Among General Practitioners.

Important dates

Study start
2021
Primary completion
2024
Study completion
2025
First posted
Aug 14, 2023
Registry last updated
Apr 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.